Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 12
Submit an article Journal homepage
106
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Autologous stem cell transplantation in peripheral T-cell lymphoma: better mobilization of blood CD34+ cells is associated with improved survival

Anu Partanena Department of Medicine, Kuopio University Hospital, Kuopio, FinlandCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-5634-2582
ORCID Icon,
Antti Turunena Department of Medicine, Kuopio University Hospital, Kuopio, Finland;b Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland
,
Jaakko Valtolaa Department of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Marja Pyöräläa Department of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Kaija Vasalac Department of Oncology, Central Hospital of Central Finland, Jyväskylä, Finland
,
Outi Kuittinenb Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;d Department of Oncology, Oulu University Hospital, Oulu, Finland;e Department of Oncology, Kuopio University Hospital, Kuopio, Finland
,
Hanne Kuitunend Department of Oncology, Oulu University Hospital, Oulu, Finland
,
Karri Penttiläf Department of Medicine, Central Hospital of Savonlinna, Savonlinna, Finland;g Finnish Medicines Agency, Kuopio, Finland
,
Taru Kuittinena Department of Medicine, Kuopio University Hospital, Kuopio, Finland
,
Pentti Mäntymaah Eastern Finland Laboratory Centre, Kuopio, Finland
,
Jukka Pelkonenh Eastern Finland Laboratory Centre, Kuopio, Finland;i Department of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland
,
Ville Varmavuoj Department of Medicine, Kymenlaakso Central Hospital, Kotka, Finland
&
Esa Jantunena Department of Medicine, Kuopio University Hospital, Kuopio, Finland;b Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland;k Siunsote-Department of Medicine, Hospital District of North Karelia, Joensuu, Finland
 show all
Pages 3027-3029 | Received 07 May 2020, Accepted 22 Jun 2020, Published online: 10 Jul 2020

References

  • Jantunen E, D'Amore F. Stem cell transplantation for peripheral T-cell lymphomas. Leuk Lymphoma. 2004;45(3):441–446.
  • Jantunen E, Sureda A. The evolving role of stem cell transplants in lymphomas. Biol Blood Marrow Transplant. 2012;18(5):660–673.
  • Corradini P, Tarella C, Zallio F, et al. Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation. Leukemia. 2006;20(9):1533–1538.
  • Reimer P, Rüdiger T, Geissinger E, et al. Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study. J Clin Oncol. 2009;27(1):106–113.
  • Wilhelm M, Smetak M, Reimer P, et al. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation. Blood Cancer J. 2016;6(7):e452–e452.
  • d'Amore F, Relander T, Lauritzsen GF, et al. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. J Clin Oncol. 2012;30(25):3093–3099.
  • Park SI, Horwitz SM, Foss FM, et al. The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: report from COMPLETE, a prospective, multicenter cohort study. Cancer. 2019;125(9):1507–1517.
  • Kyriakou C, Canals C, Goldstone A, et al. High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2008;26(2):218–224.
  • Smith SM, Burns LJ, van Besien K, et al. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma. J Clin Oncol. 2013;31(25):3100–3109.
  • Kharfan-Dabaja MA, Kumar A, Ayala E, et al. Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: An international collaborative effort on behalf of the guidelines committee of the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2017;23(11):1826–1838.
  • Jantunen E, Varmavuo V, Juutilainen A, et al. Kinetics of blood CD34(+) cells after chemotherapy plus G-CSF in poor mobilizers: implications for pre-emptive plerixafor use. Ann Hematol. 2012;91(7):1073–1079.
  • Partanen A, Valtola J, Ropponen A, et al Comparison of filgrastim, pegfilgrastim, and lipegfilgrastim added to chemotherapy for mobilization of CD34+ cells in non-Hodgkin lymphoma patients. Transfusion. 2019;59(1):325–334.
  • Jantunen E, Fruehauf S. Importance of blood graft characteristics in auto-SCT: implications for optimizing mobilization regimens. Bone Marrow Transplant. 2011;46(5):627–635.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.